Patents by Inventor Kranthi Kiran Mandadi

Kranthi Kiran Mandadi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11441156
    Abstract: The present disclosure relates, according to some embodiments, to pathogen resistant plants, compositions, organisms, systems, and methods. For example, a composition may comprise a heterologous peptide (e.g., a defensin peptide) and/or a nucleic acid (e.g., a defensin nucleic acid). A pathogen resistant plant may comprise, in some embodiments, a heterologous defensin peptide and/or an expressible nucleic acid encoding a heterologous defensin peptide.
    Type: Grant
    Filed: April 8, 2020
    Date of Patent: September 13, 2022
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: T. Erik Mirkov, Kranthi Kiran Mandadi
  • Publication number: 20200332312
    Abstract: The present disclosure relates, according to some embodiments, to pathogen resistant plants, compositions, organisms, systems, and methods. For example, a composition may comprise a heterologous peptide (e.g., a defensin peptide) and/or a nucleic acid (e.g., a defensin nucleic acid). A pathogen resistant plant may comprise, in some embodiments, a heterologous defensin peptide and/or an expressible nucleic acid encoding a heterologous defensin peptide.
    Type: Application
    Filed: April 8, 2020
    Publication date: October 22, 2020
    Applicant: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: T. Erik MIRKOV, Kranthi Kiran MANDADI
  • Patent number: 10640784
    Abstract: The present disclosure relates, according to some embodiments, to pathogen resistant citrus compositions, organisms, systems, and methods. For example, a composition may comprise a peptide (e.g., a defensin peptide) and/or a nucleic acid (e.g., a defensin nucleic acid). A pathogen resistant citrus plant may comprise, in some embodiments, a defensin peptide and/or an expressible nucleic acid encoding a defensin peptide.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: May 5, 2020
    Assignee: The Texas A&M University System
    Inventors: T. Erik Mirkov, Kranthi Kiran Mandadi
  • Publication number: 20170159069
    Abstract: The present disclosure relates, according to some embodiments, to pathogen resistant citrus compositions, organisms, systems, and methods. For example, a composition may comprise a peptide (e.g., a defensin peptide) and/or a nucleic acid (e.g., a defensin nucleic acid). A pathogen resistant citrus plant may comprise, in some embodiments, a defensin peptide and/or an expressible nucleic acid encoding a defensin peptide.
    Type: Application
    Filed: July 15, 2016
    Publication date: June 8, 2017
    Inventors: T. Erik Mirkov, Kranthi Kiran Mandadi